medical benefit

Aetna, the health, medical and benefits insurance unit of CVS Health, has now successfully secured the targeted lower pricing for its fifteenth Vitality Re health insurance catastrophe bond issuance, with the $200m of notes on offer from the Vitality Re XV Ltd (Series 2024) transaction now priced at the bottom of reduced guidance.

Aetna, the health, medical and benefits insurance unit of CVS Health, is now targeting reduced pricing for what will be its fifteenth Vitality Re health insurance catastrophe bond issuance, with spread guidance reduced for the $200m of reinsurance it hopes to receive from the Vitality Re XV Ltd (Series 2024) transaction.

Aetna, the health, medical and benefits insurance unit of CVS Health, has returned to the insurance-linked securities (ILS) market, to sponsor what will be its fifteenth Vitality Re health insurance catastrophe bond issuance, aiming for $200m of reinsurance from a Vitality Re XV Ltd (Series 2024) transaction.

Health, medical and benefit insurer Aetna’s new Vitality Re XIV Ltd (Series 2023) health insurance-linked securities (ILS) has now priced, with the multiples on offer to investors at or near historic highs for the long-standing series of health insurance linked catastrophe bond deals.

Driving home the higher spreads and pricing that are now a feature of the catastrophe bond and insurance-linked securities (ILS) market, is the fact even health, medical and benefit insurer Aetna’s latest Vitality Re XIV Ltd (Series 2023) health ILS deal now looks set to price in the upper-half of initial guidance.

Aetna, the health, medical and benefits insurance unit of CVS Health, is back in the insurance-linked securities (ILS) market to sponsor a fourteenth Vitality Re health insurance catastrophe bond issuance, targeting $200m of reinsurance from a Vitality Re XIV Ltd (Series 2023) transaction.

Aetna, the health, medical and benefits insurance unit of CVS Health, has now priced its thirteenth Vitality Re health insurance catastrophe bond structure and is on track to secure the targeted $200m of reinsurance from its Vitality Re XIII Ltd (Series 2022) transaction, with pricing at the mid and top-ends of guidance.

Aetna, the health, medical and benefits insurance unit of CVS Health, has returned to the capital market and insurance-linked securities (ILS) for issuance of its thirteenth Vitality Re health insurance catastrophe bond structure, aiming to secure $200m of reinsurance from a Vitality Re XIII Ltd (Series 2022) transaction.

Reflecting the fact insurance-linked securities (ILS) and catastrophe bond investors continue to have minimum return requirements, the pricing on Aetna’s twelfth and $200 million health insurance linked ILS deal, the Vitality Re XII Ltd (Series 2021) transaction, is likely to settle at the top-end of guidance.

Aetna, the health, medical and benefits insurance arm of CVS Health, is back in the insurance-linked securities (ILS) market with what will be the firms twelfth sponsorship of a Vitality Re, health insurance linked catastrophe bond structure, seeking $200 million of reinsurance from a Vitality Re XII Ltd (Series 2021) transaction.